Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #148
- Final score
- 63.66
- Years on list
- 6
↗ Climbed 221 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 221 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 26 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 265 since 2021
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | DHR | A | VTRS |
|---|---|---|---|
| Climate Change | 70.7 | 76.5 | 69.5 |
| Employee Relations | 74.8 | 56.1 | 62.2 |
| Environment | 54.7 | 75.2 | 69.4 |
| Stakeholders & Society | 65.9 | 72.7 | 67.5 |
| Human Rights | 55.2 | 47.4 | 41.2 |
| Governance | 48.8 | 45.7 | 53.7 |
| Performance Rating | 59.6 | 56.4 | 67.9 |